| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/02/2006 | CA2576465A1 Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 03/01/2006 | EP1629063A1 Organic electroluminescent devices and metal complex compounds |
| 03/01/2006 | EP1628978A2 Triaza-spiro compounds as nociceptin analogues and uses thereof |
| 03/01/2006 | EP1628977A2 ANTIBIOTIC TETRAHYDRO-b-CARBOLINE DERIVATIVES |
| 03/01/2006 | EP1628976A1 Novel pyridopyrazines and use thereof as kinase inhibitors |
| 03/01/2006 | EP1628975A2 Jnk inhibitors |
| 03/01/2006 | EP1628967A1 Immunosuppressant compounds and compositions |
| 03/01/2006 | EP1628661A2 Modulators of vr1 receptor |
| 03/01/2006 | EP1628533A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/01/2006 | EP1572657A4 Processes for preparing quinolonecarboxylate derivatives |
| 03/01/2006 | EP1532146B1 A method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives |
| 03/01/2006 | EP1472255B1 Aza-arylpiperazines |
| 03/01/2006 | EP1363910B1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 03/01/2006 | EP1319661B1 Process for producing a tricyclic fused heterocyclic derivative |
| 03/01/2006 | EP1319007B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/01/2006 | EP1311507B1 Fused pyrazole derivatives being protein kinase inhibitors |
| 03/01/2006 | EP1307192B1 Candesartan for treating migraine |
| 03/01/2006 | EP1086105B1 Fused azepinone cyclin dependent kinase inhibitors |
| 03/01/2006 | EP1037616B1 COMBINATION OF ALPHA-1-ADRENERGIC ANTAGONISTS AND A CGMP PDEv INHIBITOR FOR THE TREATMENT OF IMPOTENCE |
| 03/01/2006 | CN1742010A Novel chemical compounds |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 02/28/2006 | US7005523 Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines |
| 02/28/2006 | US7005435 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 02/28/2006 | US7005434 Compounds and uses thereof |
| 02/28/2006 | US7005122 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route |
| 02/28/2006 | US7005121 Arerosol; heating drug, vaporization, cooling |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/23/2006 | WO2006020082A1 Inhibitors of hcv replication |
| 02/23/2006 | WO2006020017A2 Dipeptidyl peptidase inhibitors |
| 02/23/2006 | WO2006019965A2 Dipeptidyl peptidase inhibitors |
| 02/23/2006 | WO2006019955A2 Antiviral methods and compositions |
| 02/23/2006 | WO2006019940A2 Pyrrolo(oxo)quinolines as 5ht ligands |
| 02/23/2006 | WO2006019886A2 Pyrrolo(oxo)isoquinolines as 5ht ligands |
| 02/23/2006 | WO2006019673A2 Jiadifenin analogs and uses thereof |
| 02/23/2006 | WO2006018727A2 Triazolopyridine compounds useful for the treatment of inflammation |
| 02/23/2006 | WO2006018718A2 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors |
| 02/23/2006 | WO2006018284A1 Compounds and compositions useful as cathepsin s inhibitors |
| 02/23/2006 | WO2006018279A2 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 02/23/2006 | WO2006018184A2 Spirocyclic cyclohexane derivatives |
| 02/23/2006 | WO2006001511A8 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 02/23/2006 | WO2005118557A3 Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 02/23/2006 | WO2005089118A3 Novel bicyclic compounds as modulators of androgen receptor function and method |
| 02/23/2006 | WO2005086808A3 NOVEL DICATIONIC IMIDAZO[1,2-a]PYRIDINES AND 5,6,7,8-TETRAHYDRO-IMIDAZO[1,2a]PYRIDINES AS ANTIPROTOZOAL AGENTS |
| 02/23/2006 | WO2005048953A3 Amide derivatives as kinase modulators |
| 02/23/2006 | WO2005026164A8 Pharmacologically active imidazo[4,5-c]pyridines |
| 02/23/2006 | WO2005003086A3 Sulfonic acid derivatives of polycyclic dyes used for analytical applications |
| 02/23/2006 | US20060041159 Transition metal complexes with proton sponges as ligands |
| 02/23/2006 | US20060041139 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 02/23/2006 | US20060041136 alpha-(2-chlorophenyl)-6,7dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid methyl ester (clopidogrel hydrogen sulphate); separating crystalline form out of a solution of clopidogrel in the form of the free base in a 2-propanol or n-butyl acetate solvent by adding sulphuric acid |
| 02/23/2006 | US20060041134 Silyl ethers |
| 02/23/2006 | US20060041125 Substituted pyrido-pyridazine derivatives which enhance cognition via the gaba-a receptors |
| 02/23/2006 | US20060041123 Antibacterial agents |
| 02/23/2006 | US20060041095 Intermediate products, methods for their preparation and use thereof |
| 02/23/2006 | US20060040976 Thiobenzimidazole derivatives |
| 02/23/2006 | US20060040975 Fused ring NK1 antagonists |
| 02/23/2006 | US20060040972 Pyrazolonaphthyridine derivative |
| 02/23/2006 | US20060040963 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/23/2006 | US20060040956 Substituted alkylamine derivatives and methods of use |
| 02/23/2006 | US20060040949 Treating antibiotic resistant bacterial infections; compounds based on quinoline rings; (3S)-2-(3-{[(Benzo[1,2,5]thiadiazol-5-ylmethyl)-amino]-methyl}-piperidin-1-yl)-(1RS)-(6-methoxy-quinolin-4-yl)-ethanol for example |
| 02/23/2006 | US20060040947 inflammation; N-(4-Phenylpyridin-2-yl)isoquinolin-5-amine; analgesis; antinociceptive agents |
| 02/23/2006 | US20060040941 7-Aminoimidazotriazones |
| 02/23/2006 | US20060040940 Imidazopyridines pyrimidines and triazines for enhancing cognition as gaba-a-alphas 5 receoptor subtype ligands |
| 02/23/2006 | US20060040930 Novel substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same |
| 02/23/2006 | US20060040929 (5R)-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione and method of preparation thereof |
| 02/23/2006 | US20060040925 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 02/23/2006 | US20060040918 Benzo d!azepine derivatives for the treatment of neurological disorders |
| 02/23/2006 | US20060040906 Piperazine urea derivatives as melanocortin-4 receptor agonists |
| 02/23/2006 | DE102004039382A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives |
| 02/23/2006 | CA2577648A1 Triazolopyridine compounds useful for the treatment of inflammation |
| 02/23/2006 | CA2577478A1 Triazolopyridine compounds |
| 02/23/2006 | CA2577255A1 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 02/23/2006 | CA2576619A1 Benzothienopyridines for use as inhibitors of eg5 kinesin |
| 02/23/2006 | CA2576421A1 Inhibitors of hcv replication |
| 02/23/2006 | CA2575826A1 Compounds and compositions useful as cathepsin s inhibitors |
| 02/22/2006 | EP1627880A1 Boronic ester and acid compounds, synthesis and uses |
| 02/22/2006 | EP1627877A1 Processes for producing pyrazoloacridone derivative and intermediate therefor |
| 02/22/2006 | EP1626967A1 Substituted pyrazoles |
| 02/22/2006 | EP1385839B1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/22/2006 | EP1224187B1 Certain alkylene diamine-substituted heterocycles |
| 02/22/2006 | CN1738820A Novel diazabicyclic aryl derivatives |
| 02/22/2006 | CN1738819A 4-oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors |
| 02/22/2006 | CN1738818A Method of preparing inhibitors of phosphodiesterase-4 |
| 02/22/2006 | CN1738817A Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same. |
| 02/22/2006 | CN1738816A Substituted indolepyridinium as anti-infective compounds |
| 02/22/2006 | CN1738814A Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 02/22/2006 | CN1738806A Oxo-azabicyclic compounds |
| 02/22/2006 | CN1738805A N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as CGRP-antagonists for treating a headache |
| 02/22/2006 | CN1738799A Methods for preparing phenylalkyne derivatives |
| 02/22/2006 | CN1738618A Pharmaceutical compositions and their uses |
| 02/21/2006 | US7002022 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 02/21/2006 | US7001913 substituted naphthyridine aminopiperidines; bacterial infections |
| 02/21/2006 | US7001912 Beta-carboline hydroxamic acid substituted pyrido 3,4-B indole compounds; 9-(4-fluorobenzyl)-N-hydroxy-9H- beta -carboline-3-carboxamide |
| 02/21/2006 | US7001911 Fused cyclic modulators of nuclear hormone receptor function |
| 02/21/2006 | US7001902 Cyclization in presence of Lawesson's reagent |
| 02/21/2006 | US7001900 Central nervous system disorders |
| 02/21/2006 | CA2239970C Process for preparing optically active compounds |
| 02/21/2006 | CA2175372C Novel 9-hydroxy-pyrido[1,2-a]pyrimidin-4-one ether derivatives |
| 02/16/2006 | WO2006017672A2 2, 8-disubstituted naphthyridine derivatives |
| 02/16/2006 | WO2006016067A2 Pyrido-pyrido pyrimidine derivatives, preparation thereof, therapeutic use thereof for treating cancer |
| 02/16/2006 | WO2005110409A3 Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity |